Saturday, January 13, 2024 11:53:53 AM
Replying to @Jetmek_03052 post - 334751
Only someone who is a non shareholder stamp their foot and refuse to understand facts. Instead makes them up as you go along.
Baying at the moon in the woods, claiming to have spoken to management. Not possible. Just another lie.
What is the definition of insanity?
Check out filing due Tuesday— even got regulated date wrong! MLK B’Day Monday and markets closed . Try and keep up!
__________________________
Replying to @Stock_Barber post - 334768
How many times do a few need to be corrected about out of context and omitted extracts? The height of deception and insulting to shareholders.
pontificating that one is a saintly expert, of course has had no personal gains. Sure, and the moon the other barking dogs were baying at, is made of cream cheese.
Such crap. Shareholders read the MD&A which explains why the high of $536k in 2018 eroded and Company was recovering post-Covid and Brexit and hangover of SEC Matter awaiting dismissal.
The bashers have neither run a negotiation nor run a public company and surely know nothing about structured financing. As we have said over and over DC was acquired in 2010 with the financial portion concluded in 2012.
Growth financing coincident with filing 10-K one year after conclusion in Nov 2013. Instead Company had reaudit which cost $157,300 over 2 years. Through no fault of DBMM, and documented to SEC in Release 5543.
More attempts at revisionist history , false statements to try and shake share loose. Disgusting misinformation over and over for a decade+.
DBMM long and strong.,
Recent DBMM News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 09:32:32 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/29/2023 09:31:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/17/2023 09:15:45 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM